Reduced cerebrospinal fluid monoamines in Alexander's disease: a clue to a symptomatic therapy
Eur J Neurol
.
2018 Sep;25(9):e105-e106.
doi: 10.1111/ene.13680.
Authors
M J Casarejos
1
,
G Lorenzo-Sanz
2
,
P Perez-Torres
3
,
R Mateo-Montero
4
,
M Villadoniga
4
,
A Belanger
2
,
L López-Viñas
4
,
E Bazán
1
,
J Braun
1
,
A Jimenez-Escrig
3
Affiliations
1
Department of Neurobiology, IRYCIS, Hospital Ramón y Cajal, Madrid, Spain.
2
Department of Pediatrics, Hospital Ramón y Cajal, Madrid, Spain.
3
Department of Neurology, Hospital Ramón y Cajal, Madrid, Spain.
4
Department of Clinical Neurophysiology, Hospital Ramón y Cajal, Madrid, Spain.
PMID:
30134051
DOI:
10.1111/ene.13680
No abstract available
Keywords:
Alexander's disease; GFAP; exome.
Publication types
Letter